focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'm clearly dreaming !!!! lol
Rising since yesteday...
Judging by the lack of interest on this board and others, I doubt is a P & D, looks more like an individual or institution building a position. Might get a TR1 at some point, don't think this is PIs investing. IMHO Maybe they have won a new contract of some sort? Who knows!
Was in this from 9p to 70p must be something in this rise biggest since 2013
No idea what's going on here bit had a wee dip in at 6.2. 10 mins later & its gone ballistic. Will it hold or is it just a P&D ???
Reckon there must be more going on with PHB contract and others contracts that than we know about. There must be a good reason that Roberto Sella has been willing to put up so much financing. He appears to be a pretty 'astute cookie'. (Mr. Roberto M. Sella is a Managing Partner at LL FUNDS LLC. Mr. Sella co-founded LL FUNDS LLC in 2009. Prior to this, he was a Managing Director, Co-Head of Fixed Income, and Portfolio Manager at Morgan Stanley Investment Management Inc. and The Universal Institutional Funds, Inc. - Core Plus Fixed Income Portfolio. He was a member of the fixed income team. He served as Portfolio Manager at Morgan Stanley Select Dimensions Investment Series - Flexible Income Portfolio) Bloomberg. We also have a 'Mr Dixon' buying up 6% of the stock last year. Can only be that they have some confidence in the future for CBUY, and are willing to invest their dollars. Lets hope they are right. Has been a tough time for existing shareholders, 70p to 2p over the years!
http://www.proactiveinvestors.co.uk/companies/stocktube/8522/cloudbuy-focused-on-core-products-and-eyeing-profitability-after-34mln-fundraise-8522.html The chap seems genuine.
The £1.7m should take them to profitability. If you believe that then buy. Results also due before end March with a possibility of contract wins pre this date.
Something must be going on here that we don't know about, decent rises on small amounts of buying. Perhaps it was the interview with David Gibbon in Dec? Not complaining in the least , is great to see uptrend after such a long time in the AIM wilderness! http://www.proactiveinvestors.co.uk/companies/stocktube/8522/cloudbuy-focused-on-core-products-and-eyeing-profitability-after-34mln-fundraise-8522.html
The cash injection has prevented the company going down for another 12 months. Is the market short of stock,clueless on that.If those that make the market had bet on a bucket shop placing in which they are often the only takers, then you just might be on the ball. Any squeeze will not effect the company long term as it will only be worth value if it can make profits.
It looks like the current market cap is underpinned by the current raise. If you believe that £1.7m will take them to profitability then perhaps people are taking a position. Remember there are not many shares in issue. This COULD be one of the biggest turnaround stories of 2018!
On the leader board 2 days recently! What on earth is going on. Could MMs actually be short of shares after Dixon mopped up so many a while back and the 600k share buy recently.? Very bizarre!
Some buys coming in. Love the nearly £20k buy this morn!
£3.4M new cash is now in the coffers. CBUY are of the opinion that half that amount is required to hit profitability. The jury is still out on that. Is CBUY now its fully funded, a buy.? All I can say is its in a better place than this time last month. Profits are required.
We get told that in the years to come if ever. If income does not grow this company will just take longer to die. The shares can’t move up unless buyers take a pure punt or we see evidence of higher income and a growing profit base. Next is to figure out why the man with the cash keeps the company alive. CBUY plc will be out of the game this time next week without it. He must have his reasons.
Not sure it’s not a buy till that cash has arrived that’s for sure.
"The £1.7M should be enough to hit profit. " How ae you describing "profit" , exactly? The company hasnt defined exactly what it means ....what do you mean? Profit at what level?
Dustbin - thanks. Are you a holder and do you have confidence in the recovery?
Assuming the new cash arrives by 31/12/17. The balance sheet is strengthened this might have been a requirement for winning any possible new orders. The 2017 accounts can be signed off as a going concern. The £1.7M should be enough to hit profit. The NHS order was contracted years ago it’s just a matter of increasing sales. Any stock market crash or dip in 2018 should not effect its end user, the NHS. According to the board no more funding will be required and if it is,an extra £1.7M could be called open.
The board of directors who own a slice of the company have done extremely well in raising funds just short of two years ago at 6.5P , that can be converted from loans to shares. The new funding is at just 2P in the scheme of things small shareholders could have ended up with a 5% fraction of the company. That is not going to happen mainly because the board directors would also have been stuffed, seeing their holdings go below 1% Their is a balance between the board and the investor who has pumped in more cash. That investor, believe it or not would get just over 50% if he converted on Jan 1st 2018. That’s a far cry from 75% and even further from 90%. We also need to grasp the valuation after conversion which I am guessing at today’s price would be around £6M if I have my numbers correct. If CBUY can make serious profits I am not at this stage saying they can, then in a few years if profits grew to £5M shareholders will be laughing.
Why would sella continue to put money into this? If it goes belly up and does not make money he will be left with nothing in my view so I believe he truly sees value here. The alternative is that he does see value but has his eye on owning the company
Totally agree. The market is waiting for material news. Currently the stock is priced for failure. Any sign of profitabiiity and this could rocket. Results due before end March 18! All in my view
Thanks for that link. The shares will only rise if first revenues grow and second profits materialise.
Through our work to establish personal health budgets, it quickly became obvious that not only did our process work, but that people were accessing much more cost effective support. By the end of the first year, 0 per cent of people had designed their care like our traditional offer in end of life care, all personal health budgets were either cost neutral or at a lower cost than the traditional care package, and 83 per cent of those people died in their preferred place of care – a huge increase compared with the 64 per cent of patients receiving a traditional care package on the same funding stream and the 26 per cent of the wider population who die in their preferred place.